Magellan Health, Inc. MGLN
Set alert
94.99 +94.99 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 0
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 27.86
- Beta
- 1.04
- Short ratio
- 9.84
- Inst. own
- 102.61%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 25, 2022
- 50-d avg
- 94.68
- 200-d avg
- 94.47
- 1y target
- 95.00
Analyst view
Consensus: hold
Hold
Price target (mean) 95.00
Ratings (0m) 4 2 buy · 2 hold · 0 sell
- Strong buy1
- Buy1
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 1
- 2 months ago 1
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.38 | 0.34 – 0.42 | -0.38 | +200.0% | 1.27B | +7.5% | 2 |
| Next quarter | 1.11 | 0.79 – 1.43 | 1.33 | -16.5% | 1.29B | +13.0% | 2 |
| Current year | 1.84 | 1.80 – 1.88 | 0.77 | +139.0% | 4.91B | +7.3% | 2 |
| Next year | 3.41 | 3.10 – 3.72 | 1.84 | +85.3% | 5.37B | +9.5% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 15, 2021 | Jefferies | Downgrade | Buy | Hold |
| Jan 6, 2021 | Stephens & Co. | Downgrade | Overweight | Equal-Weight |
| Sep 10, 2020 | B of A Securities | Maintained | — | Buy |
| Jul 30, 2020 | Jefferies | Maintained | — | Buy |
| Feb 22, 2019 | Bank of America | Initiated | — | Buy |
| Jan 14, 2019 | Stephens & Co. | Initiated | — | Equal-Weight |
| Nov 13, 2018 | Leerink Swann | Downgrade | Outperform | Market Perform |
| Nov 12, 2018 | Raymond James | Maintained | Outperform | Outperform |
| Jul 30, 2018 | Raymond James | Maintained | Outperform | Outperform |
| May 1, 2018 | Raymond James | Upgrade | Market Perform | Outperform |
| Jul 14, 2017 | KeyBanc | Upgrade | Sector Weight | Overweight |
| Nov 23, 2016 | Barclays | Maintained | — | Underweight |
| Sep 26, 2016 | Jefferies | Maintained | — | Buy |
| May 20, 2016 | Jefferies | Maintained | — | Buy |
| Jan 6, 2016 | Barclays | Downgrade | Equal-Weight | Underweight |
| Jul 28, 2015 | Jefferies | Maintained | — | Buy |
| May 13, 2015 | Jefferies | Upgrade | Hold | Buy |
| May 1, 2015 | Barclays | Maintained | — | Equal-Weight |
| Mar 20, 2015 | Barclays | Maintained | — | Equal-Weight |
| Feb 27, 2015 | Jefferies | Maintained | — | Hold |
| Jan 6, 2015 | Deutsche Bank | Maintained | — | Buy |
| Jul 28, 2014 | Deutsche Bank | Maintained | — | Buy |
| Jul 28, 2014 | Barclays | Maintained | — | Equal-Weight |
| Apr 29, 2014 | Jefferies | Maintained | — | Hold |
| Mar 4, 2014 | Deutsche Bank | Maintained | — | Buy |
| Feb 28, 2014 | Leerink Swann | Initiated | — | Market Perform |
| Jan 8, 2014 | Barclays | Downgrade | Overweight | Equal-Weight |
| Dec 18, 2013 | Deutsche Bank | Maintained | — | Buy |
| Jul 30, 2013 | Citigroup | Downgrade | Neutral | Sell |
| Jul 16, 2013 | Deutsche Bank | Maintained | — | Buy |